Click Here for 5% Off Your First Aladdin Purchase!

Brij® L4 - average Mn ~362, high purity , CAS No.9002-92-0

  • average Mn ~362
Item Number
B110921
Grouped product items
SKUSizeAvailabilityPrice Qty
B110921-25ml
25ml
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$9.90
B110921-100ml
100ml
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$27.90
B110921-250ml
250ml
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$52.90

Basic Description

SynonymsBrij 30;Polyethylene glycol dodecyl ether, Polyoxyethylene (4) lauryl ether ;Ethoxylated Fatty Alcohols;Tricosaethylene glycol mono-n-dodecyl ether Hydroxy-PEG-C12,Polyethylene Glycol Monolauryl Ether
Specifications & Purityaverage Mn ~362
Legal InformationBrij is a registered trademark of Croda International PLC
Storage TempArgon charged
Shipped InNormal
Product Description

Brij L4 is an ethoxylated (4) natural fatty alcohol, based on lauryl alcohol. This naturally derived surfactant offers emulsifying and detergency to a variety of applications. Chemical group Nonionic Surfactants - Ethoxylated Fatty Alcohols Manufacturer:Croda

Names and Identifiers

PubChem CID 254787116

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

19 results found

Lot NumberCertificate TypeDateItem
G2221189Certificate of AnalysisApr 07, 2024 B110921
G2221188Certificate of AnalysisApr 07, 2024 B110921
G2221187Certificate of AnalysisApr 07, 2024 B110921
G2221186Certificate of AnalysisApr 07, 2024 B110921
G2221180Certificate of AnalysisApr 07, 2024 B110921
F2207276Certificate of AnalysisMar 19, 2024 B110921
I1803011Certificate of AnalysisJan 02, 2024 B110921
C2224135Certificate of AnalysisDec 22, 2023 B110921
C2414029Certificate of AnalysisFeb 01, 2023 B110921
D2403026Certificate of AnalysisFeb 01, 2023 B110921
B2307167Certificate of AnalysisFeb 01, 2023 B110921
B2307185Certificate of AnalysisFeb 01, 2023 B110921
B2307184Certificate of AnalysisFeb 01, 2023 B110921
B2307182Certificate of AnalysisFeb 01, 2023 B110921
B2307180Certificate of AnalysisFeb 01, 2023 B110921
B2307179Certificate of AnalysisFeb 01, 2023 B110921
C2224134Certificate of AnalysisMar 14, 2022 B110921
F2207281Certificate of AnalysisMar 14, 2022 B110921
C2224131Certificate of AnalysisMar 14, 2022 B110921

more

Chemical and Physical Properties

SensitivityMoisture sensitive.
Flash Point(°C)113°C
Boil Point(°C)100℃
Melt Point(°C)37 °C

Safety and Hazards(GHS)

Pictogram(s) GHS09,   GHS07
Signal Warning
Hazard Statements

H319:Causes serious eye irritation

H302:Harmful if swallowed

H410:Very toxic to aquatic life with long lasting effects

Precautionary Statements

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P273:Avoid release to the environment.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P264:Wash hands [and …] thoroughly after handling.

P270:Do not eat, drink or smoke when using this product.

P337+P313:IF eye irritation persists: Get medical advice/attention.

P391:Collect spillage.

P330:Rinse mouth.

P301+P312:IF SWALLOWED: call a POISON CENTER/doctor/... IF you feel unwell.

Class 9

Related Documents

References

1. Ryuichi Ueoka,Yuji Komizu,Yoko Matsumoto,Yu Zhong,Ritsuko Tanaka,Naoki Yamamoto.  (2008-08-02)  Selective inhibitory effects of hybrid liposomes on the growth of HIV type 1-infected cells in vitro..  Bioorganic & medicinal chemistry letters,  18  ((16)): (4578-4580).  [PMID:18672367]
2. Woraporn Sukhumavasi,Charlotte E Egan,Amy L Warren,Gregory A Taylor,Barbara A Fox,David J Bzik,Eric Y Denkers.  (2008-08-21)  TLR adaptor MyD88 is essential for pathogen control during oral toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite..  Journal of immunology (Baltimore, Md. : 1950),  181  ((5)): (3464-3473).  [PMID:18714019]
3. Peter J McNamara,Rae Ellen Syverson,Kathy Milligan-Myhre,Olga Frolova,Sarah Schroeder,Joshua Kidder,Thanh Hoang,Richard A Proctor.  (2009-02-19)  Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1..  Antimicrobial agents and chemotherapy,  53  ((5)): (1898-1906).  [PMID:19223628]
4. Jacomina W van den Esschert,Krijn P van Lienden,Lindy K Alles,Albert C van Wijk,Michal Heger,Joris J Roelofs,Thomas M van Gulik.  (2012-01-14)  Liver regeneration after portal vein embolization using absorbable and permanent embolization materials in a rabbit model..  Annals of surgery,  255  ((2)): (311-318).  [PMID:22241291]
5. Albert-Adrien Ramelet.  (2012-01-25)  Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias..  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],  38  ((5)): (748-751).  [PMID:22268802]
6. Sabrina G Fabi,Mitchel P Goldman.  (2012-01-25)  Hand rejuvenation: a review and our experience..  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],  38  ((7 Pt 2)): (1112-1127).  [PMID:22268976]
7. S Rathbun,A Norris,J Stoner.  (2012-02-22)  Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders..  Phlebology,  27  ((3)): (105-117).  [PMID:22349606]
8. Adriana Smarandache.  (2012-03-16)  Laser beams interaction with polidocanol foam: molecular background..  Photomedicine and laser surgery,  30  ((5)): (262-267).  [PMID:22417110]
9. Darío Morais,Teresa Millás,Roberto Zarrabeitia,Luisa M Botella,Ana Almaraz.  (2012-04-04)  Local sclerotherapy with polydocanol (Aethoxysklerol®) for the treatment of Epistaxis in Rendu-Osler-Weber or Hereditary Hemorrhagic Telangiectasia (HHT): 15 years of experience..  Rhinology,  50  ((1)): (80-86).  [PMID:22469609]
10. B McAree,A Ikponmwosa,K Brockbank,C Abbott,S Homer-Vanniasinkam,M J Gough.  (2012-04-18)  Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model..  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,  43  ((6)): (721-725).  [PMID:22507925]
11. Kurosh Parsi,David E Connor,Anne Pilotelle,Joyce Low,David D F Ma,Joann.  (2012-04-26)  Low concentration detergent sclerosants induce platelet activation but inhibit aggregation due to suppression of GPIIb/IIIa activation in vitro..  Thrombosis research,  130  ((3)): (472-478).  [PMID:22531012]
12. Alessandro Frullini,Maria Chiara Barsotti,Tatiana Santoni,Emiliano Duranti,Silvia Burchielli,Rossella Di Stefano.  (2012-05-01)  Significant endothelin release in patients treated with foam sclerotherapy..  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],  38  ((5)): (741-747).  [PMID:22540861]
13. D Sato,M Kurita,M Ozaki,N Kaji,A Takushima,K Harii.  (2012-05-02)  Extravascular injection of sclerotic agents does not affect vessels in the rat: experimental implications for percutaneous sclerotherapy of arteriovenous malformations..  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,  44  ((1)): (73-76).  [PMID:22546640]
14. Takashi Yamaki,Hisato Konoeda,Daisuke Fujisawa,Kota Ogino,Atsuyoshi Osada,Atsumori Hamahata,Motohiro Nozaki,Hiroyuki Sakurai.  (2012-05-23)  Changes in calf muscle deoxygenation after foam sclerotherapy in patients with superficial venous insufficiency..  Journal of vascular surgery,  56  ((6)): (1649-1655).  [PMID:22608181]
15. Jennifer D Peterson,Mitchel P Goldman,Robert A Weiss,David M Duffy,Sabrina G Fabi,Margaret A Weiss,Isabella Guiha.  (2012-05-25)  Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline..  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],  38  ((8)): (1322-1330).  [PMID:22620717]
16. N Shadid,R Ceulen,P Nelemans,C Dirksen,J Veraart,G W Schurink,P van Neer,J vd Kley,E de Haan,A Sommer.  (2012-05-26)  Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein..  The British journal of surgery,  99  ((8)): (1062-1070).  [PMID:22627969]
17. S Reich-Schupke,A Leiste,R Moritz,P Altmeyer,M Stücker.  (2012-07-25)  Sclerotherapy in an undetected pregnancy - a catastrophe?.  VASA. Zeitschrift fur Gefasskrankheiten,  41  ((4)): (243-247).  [PMID:22825857]
18. .  (2012-08-10)  Management of chronic Achilles tendinopathy..  Drug and therapeutics bulletin,  50  ((8)): (93-96).  [PMID:22875366]
19. Amish Patel,Aaron M Fischman,Wael E Saad.  (2012-09-22)  Balloon-occluded retrograde transvenous obliteration of gastric varices..  AJR. American journal of roentgenology,  199  ((4)): (721-729).  [PMID:22997361]
20. Vikas Kumar Sarna,Njaal Stray.  (2012-10-06)  A young woman with upper gastrointestinal bleeding..  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,  132  ((18)): (2070-2072).  [PMID:23038199]
21. A Erkin,K Kosemehmetoglu,M S Diler,C Koksal.  (2012-11-06)  Evaluation of the minimum effective concentration of foam sclerosant in an ex-vivo study..  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,  44  ((6)): (593-597).  [PMID:23122185]
22. Ramon R J P van Eekeren,Doeke Boersma,Vincent Konijn,Jean Paul P M de Vries,Michel M J P Reijnen.  (2012-11-13)  Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins..  Journal of vascular surgery,  57  ((2)): (445-450).  [PMID:23141679]
23. Manuel Moretó,Enrique Ojembarrena,Angel Barturen,Ignacio Casado.  (2012-11-28)  Treatment of achalasia by injection of sclerosant substances: a long-term report..  Digestive diseases and sciences,  58  ((3)): (788-796).  [PMID:23179151]
24. Stefanie Reich-Schupke,Martin Doerler,Peter Altmeyer,Markus Stücker.  (2013-02-07)  Foam sclerotherapy with enoxaparin prophylaxis in high-risk patients with postthrombotic syndrome..  VASA. Zeitschrift fur Gefasskrankheiten,  42  ((1)): (50-55).  [PMID:23385226]
25. F Ferrara,G Ferrara.  (2013-03-16)  Treating telangiectasias: my method..  Minerva cardioangiologica,  61  ((2)): (221-227).  [PMID:23492605]
26. E Cameron,T Chen,D E Connor,M Behnia,K Parsi.  (2013-09-03)  Sclerosant foam structure and stability is strongly influenced by liquid air fraction..  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,  46  ((4)): (488-494).  [PMID:23993276]
27. G C Valenzuela,K Wong,D E Connor,M Behnia,K Parsi.  (2013-09-28)  Foam sclerosants are more stable at lower temperatures..  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,  46  ((5)): (593-599).  [PMID:24070851]
28. Otte Brosjö,Pierre Pechon,Asle Hesla,Panagiotis Tsagozis,Henrik Bauer.  (2013-11-01)  Sclerotherapy with polidocanol for treatment of aneurysmal bone cysts..  Acta orthopaedica,  84  ((5)): (502-505).  [PMID:24171682]
29. L Lund,A Kloster,T Cao.  (2013-11-23)  The long-term efficacy of hydrocele treatment with aspiration and sclerotherapy with polidocanol compared to placebo: a prospective, double-blind, randomized study..  The Journal of urology,  191  ((5)): (1347-1350).  [PMID:24262498]
30. Misaki M Kiguchi,Eric S Hager,Daniel G Winger,Stanley A Hirsch,Rabih A Chaer,Ellen D Dillavou.  (2014-01-11)  Factors that influence perforator thrombosis and predict healing with perforator sclerotherapy for venous ulceration without axial reflux..  Journal of vascular surgery,  59  ((5)): (1368-1376).  [PMID:24406088]
31. .  (2014-01-11)  Discussion..  Journal of vascular surgery,  59  ((5)): (1375-1376).  [PMID:24406091]
32. Amir M Ghaznavi,Mio Nakamura,Donna Tepper.  (2014-12-19)  An analysis of 72% chromated glycerin used for sclerotherapy: sterility, potency, and cost after extended shelf life..  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],  41  ((1)): (121-125).  [PMID:25521102]
33. Chuanyu Yang,Charles A Powell,Yongping Duan,Robert Shatters,Muqing Zhang.  (2015-07-25)  Antimicrobial Nanoemulsion Formulation with Improved Penetration of Foliar Spray through Citrus Leaf Cuticles to Control Citrus Huanglongbing..  PloS one,  10  ((7)): (e0133826-e0133826).  [PMID:26207823]

Solution Calculators